Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
乳腺癌手术期间护士催眠的阿片类药物节省效果
基本信息
- 批准号:10668632
- 负责人:
- 金额:$ 66.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2028-04-30
- 项目状态:未结题
- 来源:
- 关键词:Absence of pain sensationAddressAffectAnalgesicsAnesthesia proceduresAnxietyBreast Cancer TreatmentBreast biopsyCellular ImmunityCertified registered nurse anesthetistClinicalDataDay SurgeryDoseEuropeFatigueFentanylGeneral AnesthesiaHypnosisIleusImmunosuppressionImpaired cognitionIndividual DifferencesInfusion proceduresInterventionIntravenous AnesthesiaLaryngeal MasksLightLocal AnestheticsLocal anesthesiaMedicalMedical Care CostsMethodsMissionNauseaNeurologicNursesOperative Surgical ProceduresOpioidPainPatient Outcomes AssessmentsPatient Self-ReportPatientsPharmaceutical PreparationsPhysiologicalPopulationPostoperative Nausea and VomitingPostoperative PeriodProceduresProcessPropofolPruritusPsychological StressPsychosocial FactorPublic HealthRandomizedRecoveryRecovery RoomReportingResearchRiskScheduleSentinel Lymph Node BiopsySerious Adverse EventSurgical complicationTechniquesTestingThinkingTimeTime and Motion StudiesUnconscious StateUnited StatesUnited States National Institutes of HealthUrinary RetentionVomitingWomanabsorptionbiopsychosocialbreast lumpectomybreast surgerycancer diagnosiscancer surgerycancer therapyclinical practicecostcost effectiveeconomic evaluationefficacy evaluationexpectationhemodynamicsimprovedimproved outcomeinstrumentationintervention effectmalignant breast neoplasmmembermenmorphine equivalentopioid epidemicopioid misuseopioid sparingopioid useoutcome predictionpain sensitivitypostoperative recoverypsychologicrandomized trialresponsesatisfactionside effectstandard carestandard of caretime usetraittreatment as usualtumorwound healing
项目摘要
PROJECT SUMMARY/ABSTRACT
Breast cancer accounts for one in four cancer diagnoses in women, affecting up to one in eight women in the
United States. All patients with breast cancer undergo surgery, yet surgery is not without risks and is associated
with a multitude of side effects. Many of the complications from surgery are from the use of general anesthesia
and intra- and postoperative opioids. Side effects of general anesthesia include hemodynamic instability,
postoperative nausea and vomiting, suppression of cell-mediated immunity, cognitive impairment, and delayed
recovery. The use of opioids is also associated with postoperative nausea and vomiting, ileus, urinary retention,
pruritus, and immunosuppression. Frequently, intra- and postoperative opioid use often leads to an increased
risk for non-medical opioid use and opioid-sparing techniques are needed. Extensive data supports the use of
non-pharmacological interventions including hypnosedation (HS) for patients undergoing invasive medical
procedures. In a variety of medical populations, patients using HS report significantly less anxiety and pain,
demonstrate beneficial physiological responses, request less analgesic medication, and spend less time in the
procedure room than controls. In a number of studies, the improved patient-reported outcomes and overall
satisfaction was also paralleled by decreased medical costs. All of these previous studies either delivered the
HS during simple medical procedures (e.g., breast biopsy) or before more invasive procedures such as breast
surgery and no RCTs have provided hypnosis during surgery delivered by one of the surgical team members.
The proposed trial will randomize women and men with breast cancer scheduled for a lumpectomy ± sentinel
node biopsy to one of three groups: 1) surgery with a local anesthetic, fentanyl, and HS before and during surgery
(HS); 2) HS before surgery with usual care general anesthesia (HS-GA; propofol infusion, fentanyl, and local
anesthetic); or 3) Usual care general anesthesia (GA). The study will examine differences in opioid use, pain,
anxiety, nausea, fatigue, and cognitive dysfunction before and after surgery. Recovery will be also tracked 14
and 90 days after surgery. The study will also examine group differences in medical costs associated with
procedure time, recovery room time, and use of medications. This project will allow further exploration of HS
during surgery provided by a clinical team member and to explore the biopsychosocial processes associated
with analgesia and opioid use, anesthesia, and pain and examine baseline individual difference factors
associated with the intervention effects and recovery. We specifically propose to test the hypothesis that HS
during breast cancer surgery will result in better analgesia control along with lower opioid use, less pain and
psychological stress, and faster recovery than GA. Data from the proposed study will help to move this
intervention into the standard of care and expand the use of HS into other invasive medical procedures where
general anesthesia may be avoided.
项目概要/摘要
乳腺癌占女性癌症诊断的四分之一,影响了多达八分之一的女性
美国。所有乳腺癌患者都会接受手术,但手术并非没有风险,并且与
具有多种副作用。许多手术并发症都是由于使用全身麻醉造成的
以及术中和术后阿片类药物。全身麻醉的副作用包括血流动力学不稳定,
术后恶心呕吐、细胞免疫抑制、认知障碍和迟发
恢复。阿片类药物的使用还与术后恶心和呕吐、肠梗阻、尿潴留、
瘙痒症、免疫抑制等。通常,术中和术后阿片类药物的使用往往会导致阿片类药物的增加
需要了解非医疗阿片类药物使用的风险和阿片类药物节约技术。大量数据支持使用
对接受侵入性医疗的患者进行非药物干预,包括催眠(HS)
程序。在各种医疗人群中,使用 HS 的患者报告焦虑和疼痛明显减轻,
表现出有益的生理反应,需要更少的镇痛药物,并花更少的时间
程序室比控制室。在许多研究中,患者报告的结果和总体效果得到改善
满意度的提高还伴随着医疗费用的下降。所有这些先前的研究要么提供了
在简单的医疗程序(例如乳房活检)期间或在更具侵入性的程序(例如乳房)之前发生 HS
手术期间,没有随机对照试验在其中一名手术团队成员进行的手术期间提供催眠。
拟议的试验将随机分配患有乳腺癌并计划进行肿瘤切除术的女性和男性±哨兵
对三组之一进行淋巴结活检:1) 手术前和手术期间使用局部麻醉剂、芬太尼和 HS
(高中); 2) 手术前常规全身麻醉(HS-GA;输注异丙酚、芬太尼和局部麻醉)
麻药);或 3) 常规护理全身麻醉 (GA)。该研究将探讨阿片类药物使用、疼痛、
手术前后的焦虑、恶心、疲劳和认知功能障碍。恢复情况也将被追踪 14
以及手术后 90 天。该研究还将检查与以下疾病相关的医疗费用的群体差异:
手术时间、恢复室时间和药物的使用。该项目将进一步探索 HS
在临床团队成员提供的手术期间,探索相关的生物心理社会过程
镇痛和阿片类药物的使用、麻醉和疼痛,并检查基线个体差异因素
与干预效果和恢复有关。我们特别建议检验 HS 的假设
在乳腺癌手术期间,将带来更好的镇痛控制,同时减少阿片类药物的使用、减少疼痛和
心理压力大,恢复比GA快。拟议研究的数据将有助于推动这一目标
干预护理标准并将 HS 的使用扩展到其他侵入性医疗程序中
可以避免全身麻醉。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lorenzo Cohen其他文献
Lorenzo Cohen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lorenzo Cohen', 18)}}的其他基金
Personalized Integrative Oncology: Targeted Approaches for Optimal Outcomes
个性化综合肿瘤学:实现最佳结果的针对性方法
- 批准号:
8838465 - 财政年份:2014
- 资助金额:
$ 66.95万 - 项目类别:
Community-Based, Phase III Trial of acupuncture to treat chronic Xerostomia
针灸治疗慢性口干症的社区 III 期试验
- 批准号:
8458083 - 财政年份:2012
- 资助金额:
$ 66.95万 - 项目类别:
Community-Based, Phase III Trial of acupuncture to treat chronic Xerostomia
针灸治疗慢性口干症的社区 III 期试验
- 批准号:
8643775 - 财政年份:2012
- 资助金额:
$ 66.95万 - 项目类别:
Community-Based, Phase III Trial of acupuncture to treat chronic Xerostomia
针灸治疗慢性口干症的社区 III 期试验
- 批准号:
8296964 - 财政年份:2012
- 资助金额:
$ 66.95万 - 项目类别:
Placebo Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
针灸预防辐射引起的口干症的安慰剂对照试验
- 批准号:
8230482 - 财政年份:2011
- 资助金额:
$ 66.95万 - 项目类别:
Placebo Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
针灸预防辐射引起的口干症的安慰剂对照试验
- 批准号:
8444600 - 财政年份:2011
- 资助金额:
$ 66.95万 - 项目类别:
Placebo Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
针灸预防辐射引起的口干症的安慰剂对照试验
- 批准号:
8607153 - 财政年份:2011
- 资助金额:
$ 66.95万 - 项目类别:
Placebo Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
针灸预防辐射引起的口干症的安慰剂对照试验
- 批准号:
8043902 - 财政年份:2011
- 资助金额:
$ 66.95万 - 项目类别:
Yoga for women with breast cancer undergoing radiotherapy
适合接受放射治疗的乳腺癌女性的瑜伽
- 批准号:
8041091 - 财政年份:2010
- 资助金额:
$ 66.95万 - 项目类别:
Yoga for women with breast cancer undergoing radiotherapy
适合接受放射治疗的乳腺癌女性的瑜伽
- 批准号:
8635304 - 财政年份:2010
- 资助金额:
$ 66.95万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 66.95万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 66.95万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 66.95万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 66.95万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 66.95万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 66.95万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 66.95万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 66.95万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 66.95万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 66.95万 - 项目类别:
Research Grant














{{item.name}}会员




